Back to 4C Labs or All Bud/Flower

Dosing Look-Up Table (Estimated)

0.01/g2.5/mg THCTrace CBD
0.05/g12.5/mg THCTrace CBD
0.1/g25/mg THCTrace CBD
0.15/g37.5/mg THCTrace CBD
0.2/g50/mg THCTrace CBD
0.25/g62.5/mg THCTrace CBD
0.3/g75/mg THCTrace CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
Canada 4C Labs
Designation
T25
Cultivar/Strain
Sudz
Classification
Hybrid
Chemotype
Type I: High THC
Flower Provided
Trimmed Whole Flower
THC Potential Range (±10%)
22.5-27.5%
CBD Potential Range (±10%)
<1%
Cultivated/Produced by
Canada FAAFO
Cultivated in
Flag of Canada Canada
Irradiation
Non-Irradiated
Irradiated in
Flag of Canada Canada
Monograph Conformity
5.1.8b
Imported by
England Xeal Pharma
Imported as
Schedule I: Raw Material
Packaged in
Flag of United Kingdom United Kingdom
Packaged by
England Xeal

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Confirming Details

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Main Partner Pharmacy

Pharmacy Distributor

Dispensing Patient Pharmacies

Product Description Video Reviews0 Patient Reviews

Further information to follow.

Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

Canada About 4C Labs Ltd.

4C Labs Logo

We are a vertically-integrated medical cannabis cultivator and digital healthcare provider. A holistic solution and platform that makes medical cannabis more accessible.

Moving forward with a value-driven strategy. The 4C name was conceived from a value-first approach for our patients and doctors – which is why Care, Commitment, Choice and Change are more than just concepts to us; they are the very foundation on which our company was built.

This is reflected in the team that we have spent the last several years assembling that spans compliance, cultivation, technology, engineering and healthcare. A team with the sole focus of revolutionising medical cannabis for both patients and doctors in the UK.

4C LABS team includes Hannah Deacon, who has publicly championed access to cannabis based products for treatment of refractory epilepsies in Pediatrics. 4C LABS will work with patients and physicians to improve accessibility and availability for those who need treatment the most.

UK patients deserve access to medicines that have been tested, certified and grown organically using proven cannabis genetics. With a deep understanding of plant genetics and innovative dosing strategies, 4C LABS delivers custom tailored solutions to address patients’ specific needs.

4C LABS’ cultivation strategy is spear-headed by a Canadian Master Grower with 25+ years experience supplying sought after products to compassion centres that serve the cancer community and others who suffer from chronic illnesses

4C LABS is building a telehealth platform that offers automated consultations and streamlines the patient prescription process. In turn, our partnership with the Medical Cannabis Clinicians Society broadens our educational reach and network within the UK medical community.

4clabs.co

  Information provided is partially community sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)